Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Homocysteine and brain atrophy.

Perminder S Sachdev1

  • 1School of Psychiatry, University of New South Wales, Sydney NSW 2052, Australia. p.sachdev@unsw.edu.au

Progress in Neuro-Psychopharmacology & Biological Psychiatry
|August 17, 2005
PubMed
Summary

High homocysteine (Hcy) is linked to brain atrophy and neurodegenerative diseases like Alzheimer's. Further intervention studies are needed to confirm its role and explore potential treatments for these conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tetrahydrocannabinol and Cannabidiol in Tourette Syndrome.

NEJM evidence·2024
Same author

The Neuropathological Underpinnings of Neuropsychiatric Symptoms in Dementia.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2024
Same author

Biocompatibility and proteomic profiling of DMSA-coated iron nanocubes in a human glioblastoma cell line.

Nanomedicine (London, England)·2024
Same author

Multi-omics and pathway analyses of genome-wide associations implicate regulation and immunity in verbal declarative memory performance.

Alzheimer's research & therapy·2024
Same author

National and international collaborations to advance research into vascular contributions to cognitive decline.

Cerebral circulation - cognition and behavior·2024
Same author

Umbrella review and Delphi study on modifiable factors for dementia risk reduction.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2023

Area of Science:

  • Neuroscience
  • Biochemistry
  • Vascular Biology

Background:

  • Homocysteine (Hcy) is associated with vascular disease and brain atrophy.
  • Mechanisms include oxidative stress, DNA damage, apoptosis, excitotoxicity, and vascular wall damage.
  • Hcy is prothrombotic and proatherogenic.

Purpose of the Study:

  • To review the role of homocysteine in neurodegeneration and brain atrophy.
  • To explore the association of Hcy with cognitive impairment, Alzheimer's Disease (AD), and Parkinson Disease (PD).
  • To highlight the potential of Hcy as a target for intervention in degenerative brain disorders.

Main Methods:

  • Literature review of epidemiological and longitudinal data.
  • Analysis of proposed mechanisms linking Hcy to neurodegeneration.
  • Discussion of Hcy's role in alcohol-related brain atrophy.

Main Results:

  • Hcy is implicated in brain atrophy, particularly in older individuals, and potentially white matter hyperintensities (WMH).
  • Epidemiological data support Hcy as a risk factor for cognitive impairment and AD, possibly via cerebrovascular and neurotoxic pathways.
  • The role of Hcy in PD is less established, but it may mediate alcohol-related brain atrophy.

Conclusions:

  • High homocysteine is a significant risk factor for vascular disease and neurodegeneration.
  • Its prevalence and treatability make it a promising target for future intervention studies.
  • Further intervention studies are crucial to confirm Hcy's etiological role in degenerative brain disorders.

Related Experiment Videos